- Home
- VBNK vs ORIC Comparison
VBNK vs ORIC Comparison
Compare VBNK & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VBNK
- ORIC
- Stock Information
- Founded
- VBNK 1980
- ORIC 2014
- Country
- VBNK Canada
- ORIC United States
- Employees
- VBNK N/A
- ORIC N/A
- Industry
- VBNK Commercial Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- VBNK Finance
- ORIC Health Care
- Exchange
- VBNK Nasdaq
- ORIC Nasdaq
- Market Cap
- VBNK 441.5M
- ORIC 362.9M
- IPO Year
- VBNK 2021
- ORIC 2020
- Fundamental
- Price
- VBNK $11.63
- ORIC $8.17
- Analyst Decision
- VBNK Strong Buy
- ORIC Strong Buy
- Analyst Count
- VBNK 3
- ORIC 8
- Target Price
- VBNK $19.00
- ORIC $18.83
- AVG Volume (30 Days)
- VBNK 27.3K
- ORIC 1.6M
- Earning Date
- VBNK 06-04-2025
- ORIC 05-05-2025
- Dividend Yield
- VBNK 0.62%
- ORIC N/A
- EPS Growth
- VBNK N/A
- ORIC N/A
- EPS
- VBNK 0.89
- ORIC N/A
- Revenue
- VBNK $75,813,751.00
- ORIC N/A
- Revenue This Year
- VBNK $12.97
- ORIC N/A
- Revenue Next Year
- VBNK $43.72
- ORIC N/A
- P/E Ratio
- VBNK $15.69
- ORIC N/A
- Revenue Growth
- VBNK N/A
- ORIC N/A
- 52 Week Low
- VBNK $8.51
- ORIC $3.90
- 52 Week High
- VBNK $18.38
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- VBNK 57.40
- ORIC 72.38
- Support Level
- VBNK $11.17
- ORIC $5.52
- Resistance Level
- VBNK $12.00
- ORIC $8.44
- Average True Range (ATR)
- VBNK 0.34
- ORIC 0.63
- MACD
- VBNK 0.01
- ORIC 0.32
- Stochastic Oscillator
- VBNK 61.86
- ORIC 93.11
About VBNK VersaBank
VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.